Table 5 Univariate analysis of DRG based costs distributed by infectious condition
Reimbursement (EUR) | Cases (n = 95) | Controls (n = 346) | Linear regression with log(reimbursement) as outcome | ||||
|---|---|---|---|---|---|---|---|
Median (IQR) | Mean (SD) | Median (IQR) | Mean (SD) | Coef | 95% CI | p-value | |
All patients (n = 95/441) | 5174 (3347–9059) | 13,233 (26,899) | 3762 (2405–6669) | 7198 (18,159) | 0.37 | 0.19–0.54 | <0.05 |
• No infections (n = 42/227) | 6423 (3603–8445) | 13,208 (26,850) | 3680 (2103–6669) | 7797 (22,619) | 0.48 | 0.22–0.74 | <0.05 |
• Any infection (n = 53/214) | 4560 (3148–11,178) | 13,252 (27,195) | 4355 (3148–6326) | 6511 (11,033) | 0.21 | −0.03 – 0.45 | 0.09 |
- Non-severe infections (n = 31/131) | 3450 (2523–5794) | 8065 (18,243) | 3347 (2523–5794) | 5299 (12,802) | 0.09 | −0.25 – 0.44 | 0.60 |
- Severe infections (n = 15/65) | 7600 (5794–21,931) | 26,904 (41,802) | 7600 (4560–7600) | 9300 (7268) | 0.47 | 0.15–0.79 | <0.05 |